Daré Bioscience, Inc.
DARE
$1.92
$0.073.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -617.02% | -230.55% | -384.47% | -158.33% | 94.19% |
| Total Depreciation and Amortization | 880.69% | 3,805.44% | 2,348.80% | 1,332.53% | 421.66% |
| Total Amortization of Deferred Charges | -2,400.00% | -- | 340.64% | -226.94% | -200.00% |
| Total Other Non-Cash Items | -17.07% | -41.82% | 3.24% | 5.06% | 9.98% |
| Change in Net Operating Assets | -137.71% | -103.58% | 213.77% | 173.93% | 280.24% |
| Cash from Operations | -245.77% | -280.61% | 24.80% | -14.36% | 123.06% |
| Capital Expenditure | 68.48% | 32.77% | -20.06% | 69.15% | -13.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 68.48% | 32.77% | -20.06% | 69.15% | -13.55% |
| Total Debt Issued | -13.35% | -13.35% | -13.35% | -6.57% | -6.57% |
| Total Debt Repaid | -378.78% | -213.88% | -149.19% | -69.74% | -5.91% |
| Issuance of Common Stock | 2,951.53% | 4,514.20% | 1,564.90% | -89.60% | -92.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -317.41% | -294.72% | -101.69% | -101.69% | -101.76% |
| Cash from Financing | 3,019.57% | 5,337.83% | 217.30% | -96.95% | -95.91% |
| Foreign Exchange rate Adjustments | 347.44% | 110.60% | -158.52% | -191.05% | 41.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.89% | 73.76% | 539.12% | -473.02% | 142.01% |